Pancreatic Cancer Research

ResearcherTranslational Genomics Research InstituteActive in the last 2 years

Derek Cridebring

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5630-0350; OpenAlex author ID A5048652560. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
65
Papers, trials and grants by year

2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 4 papers

Papers 13

  1. A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancre… Co-author DOI 10.1002/cncr.70343↗
  2. Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41591-026-04625-x↗
  3. Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma Co-author DOI 10.1038/s41591-026-04775-y↗
  4. Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer. Co-author DOI 10.36401/jipo-25-20↗
  5. Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-025-03167-2↗
  6. Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction. Co-author DOI 10.1093/oncolo/oyae323↗
  7. Clinical Characteristics and Survival in Patients with Brain Metastases From Pancreatic Cancer: A Retrospective Observational Study. First author DOI 10.1177/10732748251347844↗
  8. Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer. Co-author DOI 10.1016/j.ccell.2023.09.008↗
  9. An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Co-author DOI 10.1053/j.gastro.2022.06.090↗
  10. Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic Cancer. First author DOI 10.1002/onco.13645↗
  11. Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.678617↗
  12. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Co-author DOI 10.1186/s13073-020-00776-9↗
  13. Extracellular Vesicles in Diagnosis and Treatment of Pancreatic Cancer: Current State and Future Perspectives. Co-author DOI 10.3390/cancers12061530↗

Closest collaborators

The 25 strongest of 65 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniel D. Von Hoff · 12 shared papers, 2020–2026 · strength 2.03
  2. Erkut Hasan Borazanci · 9 shared papers, 2020–2026 · strength 1.59
  3. Haiyong Han · 9 shared papers, 2020–2026 · strength 1.53
  4. Ajay Goel · 6 shared papers, 2020–2026 · strength 0.98
  5. Gayle Jameson · 5 shared papers, 2020–2026 · strength 0.98
  6. Vincent M. Chung · 4 shared papers, 2021–2026 · strength 0.71
  7. Carlos Roberto Becerra · 4 shared papers, 2022–2026 · strength 0.70
  8. Mitsuro Kanda · 3 shared papers, 2025–2026 · strength 0.61
  9. Joon Oh Park · 4 shared papers, 2020–2026 · strength 0.59
  10. Susan Haag · 1 shared paper, 2025 · strength 0.54
  11. John S. Bolton · 3 shared papers, 2022–2026 · strength 0.50
  12. Scott A. Celinski · 3 shared papers, 2022–2026 · strength 0.50
  13. Eunsung Jun · 3 shared papers, 2022–2026 · strength 0.50
  14. Angela Tatiana Alistar · 2 shared papers, 2025–2026 · strength 0.42
  15. Caiming Xu · 2 shared papers, 2026 · strength 0.39
  16. Laleh Golkar Melstrom · 2 shared papers, 2026 · strength 0.39
  17. Giulia Martina Cavestro · 2 shared papers, 2026 · strength 0.39
  18. Douglas B. Evans · 2 shared papers, 2026 · strength 0.39
  19. David L. Bartlett · 2 shared papers, 2026 · strength 0.39
  20. Alessandro Mannucci · 2 shared papers, 2026 · strength 0.39
  21. Song Cheol Kim · 2 shared papers, 2026 · strength 0.39
  22. Dong Shang · 2 shared papers, 2026 · strength 0.39
  23. Mustafa Raoof · 2 shared papers, 2026 · strength 0.39
  24. Susan Tsai · 2 shared papers, 2023–2025 · strength 0.35
  25. Muhammad Rizwan Khawaja · 1 shared paper, 2026 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.